Gyre Therapeutics (GYRE) Inventory Average (2024 - 2026)
Gyre Therapeutics (GYRE) posted quarterly Inventory Average of $10.8 million for Q1 2026, up 51.41% year-over-year from $7.1 million in Q1 2025, and up 13.13% quarter-over-quarter from $9.5 million in Q4 2025.
Gyre Therapeutics (GYRE) Inventory Average (2024 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Inventory Average for 3 consecutive years, with $10.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 51.41% year-over-year to $10.8 million; the TTM figure through Mar 2026 stood at $10.8 million (up 51.41% YoY), while the FY2025 annual figure was $8.3 million, up 55.47% from the prior year.
- Inventory Average rose to $10.8 million in Q1 2026 per GYRE's latest filing, from $9.5 million in the prior quarter.
- Across five years, Inventory Average topped out at $10.8 million in Q1 2026 and bottomed at $4.6 million in Q1 2024.
- Historically, Inventory Average has averaged $7.4 million across 3 years, with a median of $7.1 million in 2025.
- On a YoY basis, Inventory Average climbed as much as 58.3% in 2025 and fell as far as 47.45% in 2025.
- Gyre Therapeutics' Inventory Average stood at $6.4 million in 2024, then jumped by 49.61% to $9.5 million in 2025, then rose by 13.13% to $10.8 million in 2026.
- Business Quant data shows GYRE's Inventory Average at $10.8 million in Q1 2026, $9.5 million in Q4 2025, and $8.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | 11.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.39 Mn |
| Mar 31, 2026 | 10.76 Mn |
| Dec 31, 2025 | 9.51 Mn |
| Sep 30, 2025 | 8.86 Mn |
| Jun 30, 2025 | 8.37 Mn |
| Mar 31, 2025 | 7.11 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 6.01 Mn |
| Jun 30, 2024 | 5.29 Mn |
| Mar 31, 2024 | 4.61 Mn |